TSS
TNXP icon

Two Sigma Securities’s Tonix Pharmaceuticals TNXP Stock Holding History

Two Sigma Securities’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8
Closed -$39.2K – 3488
2023
Q2 		$39.2K Buy
8
+7
+700% +$53.1K ﹤0.01% 2430
2023
Q1 		$14.4K Sell
1
-2
-67% -$34.3K ﹤0.01% 2407
2022
Q4 		$21.6K Buy
+3
New +$25.9K ﹤0.01% 2265
2020
Q4 		– Hold
0
– -$16K – 1948
2020
Q3 		– Hold
0
– – – 1238
2018
Q4 		– Hold
0
– -$25K – 2830
2018
Q3 		– Hold
0
– – – 2417
2018
Q1 		– Hold
0
– -$37K – 2955
2017
Q4 		– Hold
0
– – – 1571
2017
Q3 		– Hold
0
– -$59K – 1218
2017
Q2 		– Hold
0
– – – 705
2016
Q4 		– Hold
0
– -$12K – 942
2016
Q3 		– Hold
0
– – – 622

Other funds holding TNXP

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Two Sigma Securities's TNXP Position: Q3 2023 in Review

Two Sigma Securities sold out of Tonix Pharmaceuticals (TNXP) in Q3 2023, closing a stake of 8 shares — an estimated $39.2K sold.

Two Sigma Securities first reported a position in TNXP in Q4 2022 and held it in 3 quarters. The position peaked at $39.2K in Q2 2023. 14 funds tracked by Wall St. Rank hold TNXP as of Q3 2023.

  • Two Sigma Securities reported no remaining Tonix Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 8 Tonix Pharmaceuticals shares in Q3 2023, an estimated $39.2K.
  • Two Sigma Securities first reported a position in Tonix Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • Two Sigma Securities's Tonix Pharmaceuticals position peaked at $39.2K in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.